Opinion: Testing-the-waters communications allow companies, founders and sponsors to confidentially assess investor interest ...

The IPO window has reopened, but diversity hasn’t followed suit. According to research performed by Free Float Analytics’ cofounder Damion Rallis, 88% of the 61 companies filing to go public in August ...

The IPO class of 2026 is likely to receive its first incumbent, after Aktis Oncology set its sights on a public listing that could see proceeds of around $210m. The cancer treatment-focused biotech ...

Initial public offerings are back in fashion, and the temptation is to treat every debut like a lottery ticket. In a market that rewards speed and narrative, the investors who actually keep their ...